Paxillin binding is not the sole determinant of focal adhesion localization or dominant-negative activity of focal adhesion kinase/focal adhesion kinase-related nonkinase

被引:58
|
作者
Cooley, MA
Broome, JM
Ohngemach, C
Romer, LH
Schaller, MD [1 ]
机构
[1] Univ N Carolina, Dept Cell Biol & Anat, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Anesthesiol, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
关键词
D O I
10.1091/mbc.11.9.3247
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The carboxy-terminal 150 residues of the focal adhesion kinase (FAK) comprise the focal adhesion-targeting sequence, which is responsible for its subcellular localization. The mechanism of focal adhesion targeting has not been fully elucidated. We describe a mutational analysis of the focal adhesion-targeting sequence of FAK to further examine the mechanism of focal adhesion targeting and explore additional functions encoded by the carboxy-terminus of FAK. The results demonstrate that paxillin binding is dispensable for focal adhesion targeting of FAK. Cell adhesion-dependent tyrosine phosphorylation strictly correlated with the ability of mutants to target to focal adhesions. Focal adhesion targeting was also a requirement for maximal FAK-dependent tyrosine phosphorylation of paxillin and FAK-related nonkinase (FRNK)-dependent inhibition of endogenous FAK function. However, there were additional requirements for these latter functions because we identified mutants that target to focal adhesions, yet are defective for the induction of paxillin phosphorylation or the dominant-negative function of FRNK. Furthermore, the paxillin-binding activity of FRNK mutants did not correlate with their ability to inhibit FAK, suggesting that FRNK has other targets in addition to paxillin.
引用
收藏
页码:3247 / 3263
页数:17
相关论文
共 50 条
  • [41] EXPRESSION AND LOCALIZATION OF FOCAL ADHESION KINASE IN HUMAN KERATINOCYTES
    GATES, RE
    NANNEY, LB
    LI, LY
    STRICKLIN, GP
    [J]. CLINICAL RESEARCH, 1992, 40 (04): : A800 - A800
  • [42] Requirement for focal adhesion kinase in tumor cell adhesion
    Maung, K
    Easty, DJ
    Hill, SP
    Bennett, DC
    [J]. ONCOGENE, 1999, 18 (48) : 6824 - 6828
  • [43] Focal adhesion kinase-An emerging viable target in cancer and development of focal adhesion kinase inhibitors
    Chauhan, Akshita
    Khan, Tabassum
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2021, 97 (03) : 774 - 794
  • [44] Differential signaling by the focal adhesion kinase and cell adhesion kinase beta
    Schaller, MD
    Sasaki, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) : 25319 - 25325
  • [45] Minimal features of paxillin that are required for the tyrosine phosphorylation of focal adhesion kinase
    Wade, R
    Vande Pol, S
    [J]. BIOCHEMICAL JOURNAL, 2006, 393 : 565 - 573
  • [46] Focal adhesion kinase and paxillin may be early targets of ethacrynic acid
    Harding, T
    OBrien, ET
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 5068 - 5068
  • [47] Focal adhesion kinase (FAK): a determinant of pancreatic cancer invasiveness
    Ito, H
    Gardner-Thorpe, J
    Zinner, MJ
    Ashley, SW
    Whang, EE
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A802 - A802
  • [48] Dynamics of focal adhesion kinase and paxillin in migration of living endothelial cells
    Hu, Ying-Li
    Lu, Shaoying
    Wang, Yingxiao
    Chien, Shu
    [J]. FASEB JOURNAL, 2011, 25
  • [49] Focal adhesion kinase and paxillin: Novel regulators of brain sexual differentiation?
    Speert, Debra B.
    Konkle, Anne T. M.
    Zup, Susan L.
    Schwarz, Jaclyn M.
    Shiroor, Chaitanya
    Taylor, Michael E.
    McCarthy, Margaret M.
    [J]. ENDOCRINOLOGY, 2007, 148 (07) : 3391 - 3401
  • [50] CHARACTERIZATION OF TYROSINE PHOSPHORYLATION OF PAXILLIN IN-VITRO BY FOCAL ADHESION KINASE
    BELLIS, SL
    MILLER, JT
    TURNER, CE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (29) : 17437 - 17441